Preoperative tumor size ≥ 5 cm, tumor without capsule, portal vein thrombosis, poorly differentiated tumors, major hepatectomy, preoperative AFP ≥ 200 ng / mL, BCLC stage B or C, AFP 2 months after surgery ≥ 20 ng / mL as the risk factors related to early recurrence within 12 months after surgery.